IRB Meeting Dates and Submission Deadlines

MCP IRB committee meets every 2nd Wednesday of each month from 12:00 PM to 1:00 PM. Per regulations, IRB members must be provided with research materials sufficiently in advance to allow review of the material to prepare for any deliberation and voting. Per local policy, this is generally one week before the meeting. Therefore, the submission deadline is ten (10) business days before each IRB meeting to allow for any changes and to meet the review timeline. Submit materials following the IRB submission checklist and instructions on each applicable form.

Below is a schedule of IRB meetings and submission deadlines for Initial, continuing and amendment (modification) applications that involve greater than minimal risk to subjects. Submit all documents via For all IRB submissions, an original signature is not required. The Principal Investigator must sign all packages before they are submitted for IRB review.

IRB Meeting Date Submission Deadline
January 9, 2019 December 26, 2018
February 13, 2019 January 30, 2019
March 13, 2019 February 27, 2019
April 10, 2019 March 27, 2019
May 8, 2019 April 24, 2019
June 12, 2019 May 29, 2019
July 10, 2019 June 26, 2019
August 14, 2019 July 31, 2019
September 11, 2019 August 28, 2019
October 9, 2019 September 25, 2019
November 13, 2019 October 30, 2019
December 11, 2019 November 27, 2019
January 8, 2020 December 25, 2019
February 12, 2020 January 29, 2020
March 11, 2020 February 26, 2020
April 8, 2020 March 25, 2020

*Note: Submissions received on the deadline date must be complete and review ready to be placed on the Agenda for review at next convened board meeting.

Training and Education

MCP IRB requires all individuals involved in the conduct of human subjects research to complete human subjects protection training and to ensure that training is current for every year while the study is under active IRB oversight. IRB approval will be withheld if these training requirements are not met.

These requirements apply to all persons with a significant role in the research, such as those designated as:

  • Principal Investigator and Co-investigators,
  • Individuals named on a study grant or contract proposal,
  • Individuals listed on an FDA form 1572 for the conduct of the research at MCP or at an affiliate institution,
  • Individuals named as a contact person in the informed consent document(s) or recruitment materials for research,
  • Individuals who obtain informed consent from prospective participants in research, and
  • Individuals who obtain individually identifiable health information under a Business Associate Agreement.

At a minimum, MCP IRB will accept evidence of completion of the online National Institutes of Health (NIH) Office of Extramural Research module entitled “Protecting Human Research Participants” or The Collaborative Institutional Training Initiative (CITI) program training.

NIH training

CITI training

If training was completed at another institution, please upload a copy of the training certificate to IRBNet with the materials for the particular review package.